about
Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesFactors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective AnalysisThe seasonality of tuberculosis, sunlight, vitamin D, and household crowding.Evaluation of bleach-sedimentation for sterilising and concentrating Mycobacterium tuberculosis in sputum specimens.Optimizing tuberculosis testing for basic laboratoriesChallenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis.The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessmentComparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority studyMulticenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance.Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.Immunodiagnosis of tuberculosis: state of the art.Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis.Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.Diagnostic Test Accuracy in Childhood Pulmonary Tuberculosis: A Bayesian Latent Class Analysis.Impact of point-of-care implementation of Xpert® MTB/RIF: product vs. process innovation.The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.Surrogate endpoints in global health research: still searching for killer apps and silver bullets?An evaluation framework for new tests that predict progression from tuberculosis infection to clinical diseaseXpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistanceXpert ® MTB/RIF for extra-pulmonary tuberculosis: time to look beyond accuracyPerformance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis: Table 1–Screening for tuberculosis: time to move beyond symptomsXpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.Diagnostic Test for Incipient Tuberculosis: A Step Forward, Many More to GoWhat if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of TuberculosisImproving the design of studies evaluating the impact of diagnostic tests for tuberculosis on health outcomes: a qualitative study of perspectives of diverse stakeholdersIncipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of InfectionAdoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriersGuidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design PrinciplesGuidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose TuberculosisGuidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose TuberculosisGuidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility TestsGuidance for Studies Evaluating the Accuracy of Tuberculosis Triage TestsDiagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIVThe impact of Xpert MTB/RIF-do we have a final answer?A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB'SILVAMP TB LAM' rapid urine tuberculosis test predicts mortality in hospitalized HIV patients in South AfricaDiagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus
P50
Q26767271-8EBABCFB-D271-4453-A0FF-3807A0735FCFQ28550398-142E9FF1-873C-4D35-A2F5-6DFA42681826Q34034066-D7D24CEC-8A3C-4C89-A282-6C312EACEB10Q34045346-DA3A1C22-8889-4EFA-AC8F-2A583CCDFF73Q34160174-CFEF7276-597B-4FA5-A0AF-959335615647Q35078580-0764F86C-E0EF-4665-BF56-46190E2E3941Q35177840-F2217965-DD00-4537-98A2-DB591F5FC2EDQ36322028-8A4560EE-A2FA-432A-86B2-D53070FEFBC8Q36933148-96F40505-A507-4281-AD15-0A9610A63940Q37692611-5A782F9B-3D4F-4876-BB16-F159B988F3E5Q37949170-3AF07DDB-20A5-4C94-B1D8-56E9E5A736FDQ38201669-B5CE5595-8D62-42BA-BDA1-DDCC498DE6D6Q39094119-C2D99A49-A8E4-421B-81C3-CEC6BAD5BB2FQ39294206-01991231-4250-4370-99A2-5B07D3D2F65EQ41060035-6285DBDE-135F-4F29-BFE8-A76AFA5453A4Q41546193-8F57D48C-5AE9-40A5-A868-67AAF5AD87F5Q47121800-872AF0DC-466C-4F46-A914-EFFB015F5F84Q47202008-6B062A88-1093-4D0B-BB9F-4E09DB6B4F5AQ52614515-EB478C2D-5AE2-44FA-8DC6-709612403DDFQ57167773-266DF816-E5E6-4C8D-8147-2D7877E5450AQ57688853-E43D0275-E067-4F56-B416-48CE0D880F9AQ59200588-D326D6A7-BC3C-43F1-9CA6-B6628054DEA2Q59200628-AE1AF8F7-9519-4BA4-926B-F0BEB3BF8482Q62486531-9EB21DF5-DEB4-4E07-A27E-52860B00191DQ64892191-164F4C5A-8DDF-46CF-94E3-BA3137584622Q88290495-577D83CF-0A3F-4A1E-82A0-2F8730E15BFBQ89456938-0F047264-E3CC-48B6-8A0C-741D852E0376Q90057515-FC44108A-38FF-4ECE-B50F-9224F245A1E7Q90320848-AE110216-D101-4652-984C-70AF5F3B48A1Q90415681-A85ADE8F-4D53-4C24-90CC-B5C50432D806Q90590075-828C09F2-58C0-4C26-A40A-2E864603F1A1Q90590082-761AF5B5-8C15-483B-8838-6FFC9D12E312Q90590087-90225778-8825-4E73-A115-F93BEB495F7EQ90590093-639E767C-DAAC-43F7-903B-774655E307F2Q90590098-C904D94C-7573-49E2-A2F3-16E48FAB6527Q91172675-C316480C-B163-4371-89DD-CF95EF724C59Q91226781-AF8EA45B-CCCA-4ED5-8AC3-68B38DE5D977Q92472023-E8A54B3C-0696-4778-8115-A2DCCDC91837Q92518216-3007ACD3-C158-4F35-AED1-E41064DAE8A7Q92901913-69CF1F21-CACB-4480-9EEB-5384C9F9A587
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Samuel G Schumacher
@ast
Samuel G Schumacher
@en
Samuel G Schumacher
@es
Samuel G Schumacher
@nl
type
label
Samuel G Schumacher
@ast
Samuel G Schumacher
@en
Samuel G Schumacher
@es
Samuel G Schumacher
@nl
prefLabel
Samuel G Schumacher
@ast
Samuel G Schumacher
@en
Samuel G Schumacher
@es
Samuel G Schumacher
@nl
P106
P21
P31
P496
0000-0002-6136-206X